LRRK2 and Parkinson disease: Indeed, it has been reported that LRRK2 kinase inhibition is beneficial against aSyn aggregation and neurodegeneration, highlighting that these effects are dependent on LRRK2 kinase activity25 and even more important because PD-associated mutations in LRRK2 increase its kinase activity71.